Cargando…
Decentralized facility financing versus performance-based payments in primary health care: a large-scale randomized controlled trial in Nigeria
BACKGROUND: Health system financing presents a challenge in many developing countries. We assessed two reform packages, performance-based financing (PBF) and direct facility financing (DFF), against each other and business-as-usual for maternal and child healthcare (MCH) provision in Nigeria. METHOD...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8452448/ https://www.ncbi.nlm.nih.gov/pubmed/34544415 http://dx.doi.org/10.1186/s12916-021-02092-4 |
_version_ | 1784570069412478976 |
---|---|
author | Khanna, Madhulika Loevinsohn, Benjamin Pradhan, Elina Fadeyibi, Opeyemi McGee, Kevin Odutolu, Oluwole Fritsche, Gyorgy Bela Meribole, Emmanuel Vermeersch, Christel M. J. Kandpal, Eeshani |
author_facet | Khanna, Madhulika Loevinsohn, Benjamin Pradhan, Elina Fadeyibi, Opeyemi McGee, Kevin Odutolu, Oluwole Fritsche, Gyorgy Bela Meribole, Emmanuel Vermeersch, Christel M. J. Kandpal, Eeshani |
author_sort | Khanna, Madhulika |
collection | PubMed |
description | BACKGROUND: Health system financing presents a challenge in many developing countries. We assessed two reform packages, performance-based financing (PBF) and direct facility financing (DFF), against each other and business-as-usual for maternal and child healthcare (MCH) provision in Nigeria. METHODS: We sampled 571 facilities (269 in PBF; 302 in DFF) in 52 districts randomly assigned to PBF or DFF, and 215 facilities in 25 observable-matched control districts. PBF facilities received $2 ($1 for operating grants plus $1 for bonuses) for every $1 received by DFF facilities (operating grants alone). Both received autonomy, supervision, and enhanced community engagement, isolating the impact of additional performance-linked facility and health worker payments. Facilities and households with recent pregnancies in facility catchments were surveyed at baseline (2014) and endline (2017). Outcomes were Penta3 immunization, institutional deliveries, modern contraceptive prevalence rate (mCPR), four-plus antenatal care (ANC) visits, insecticide-treated mosquito net (ITN) use by under-fives, and directly observed quality of care (QOC). We estimated difference-in-differences with state fixed effects and clustered standard errors. RESULTS: PBF increased institutional deliveries by 10% points over DFF and 7% over business-as-usual (p<0.01). PBF and DFF were more effective than business-as-usual for Penta3 (p<0.05 and p<0.01, respectively); PBF also for mCPR (p<0.05). Twenty-one of 26 QOC indicators improved in both PBF and DFF relative to business-as-usual (p<0.05). However, except for deliveries, PBF was as or less effective than DFF: Penta3 immunization and ITN use were each 6% less than DFF (p<0.1 for both) and QOC gains were also comparable. Utilization gains come from the middle of the rural wealth distribution (p<0.05). CONCLUSIONS: Our findings show that both PBF and DFF represent significant improvements over business-as-usual for service provision and quality of care. However, except for institutional delivery, PBF and DFF do not differ from each other despite PBF disbursing $2 for every dollar disbursed by DFF. These findings highlight the importance of direct facility financing and decentralization in improving PHC and suggest potential complementarities between the two approaches in strengthening MCH service delivery. TRIAL REGISTRATION: ClinicalTrials.gov NCT03890653; May 8, 2017. Retrospectively registered. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12916-021-02092-4. |
format | Online Article Text |
id | pubmed-8452448 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-84524482021-09-21 Decentralized facility financing versus performance-based payments in primary health care: a large-scale randomized controlled trial in Nigeria Khanna, Madhulika Loevinsohn, Benjamin Pradhan, Elina Fadeyibi, Opeyemi McGee, Kevin Odutolu, Oluwole Fritsche, Gyorgy Bela Meribole, Emmanuel Vermeersch, Christel M. J. Kandpal, Eeshani BMC Med Research Article BACKGROUND: Health system financing presents a challenge in many developing countries. We assessed two reform packages, performance-based financing (PBF) and direct facility financing (DFF), against each other and business-as-usual for maternal and child healthcare (MCH) provision in Nigeria. METHODS: We sampled 571 facilities (269 in PBF; 302 in DFF) in 52 districts randomly assigned to PBF or DFF, and 215 facilities in 25 observable-matched control districts. PBF facilities received $2 ($1 for operating grants plus $1 for bonuses) for every $1 received by DFF facilities (operating grants alone). Both received autonomy, supervision, and enhanced community engagement, isolating the impact of additional performance-linked facility and health worker payments. Facilities and households with recent pregnancies in facility catchments were surveyed at baseline (2014) and endline (2017). Outcomes were Penta3 immunization, institutional deliveries, modern contraceptive prevalence rate (mCPR), four-plus antenatal care (ANC) visits, insecticide-treated mosquito net (ITN) use by under-fives, and directly observed quality of care (QOC). We estimated difference-in-differences with state fixed effects and clustered standard errors. RESULTS: PBF increased institutional deliveries by 10% points over DFF and 7% over business-as-usual (p<0.01). PBF and DFF were more effective than business-as-usual for Penta3 (p<0.05 and p<0.01, respectively); PBF also for mCPR (p<0.05). Twenty-one of 26 QOC indicators improved in both PBF and DFF relative to business-as-usual (p<0.05). However, except for deliveries, PBF was as or less effective than DFF: Penta3 immunization and ITN use were each 6% less than DFF (p<0.1 for both) and QOC gains were also comparable. Utilization gains come from the middle of the rural wealth distribution (p<0.05). CONCLUSIONS: Our findings show that both PBF and DFF represent significant improvements over business-as-usual for service provision and quality of care. However, except for institutional delivery, PBF and DFF do not differ from each other despite PBF disbursing $2 for every dollar disbursed by DFF. These findings highlight the importance of direct facility financing and decentralization in improving PHC and suggest potential complementarities between the two approaches in strengthening MCH service delivery. TRIAL REGISTRATION: ClinicalTrials.gov NCT03890653; May 8, 2017. Retrospectively registered. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12916-021-02092-4. BioMed Central 2021-09-21 /pmc/articles/PMC8452448/ /pubmed/34544415 http://dx.doi.org/10.1186/s12916-021-02092-4 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Article Khanna, Madhulika Loevinsohn, Benjamin Pradhan, Elina Fadeyibi, Opeyemi McGee, Kevin Odutolu, Oluwole Fritsche, Gyorgy Bela Meribole, Emmanuel Vermeersch, Christel M. J. Kandpal, Eeshani Decentralized facility financing versus performance-based payments in primary health care: a large-scale randomized controlled trial in Nigeria |
title | Decentralized facility financing versus performance-based payments in primary health care: a large-scale randomized controlled trial in Nigeria |
title_full | Decentralized facility financing versus performance-based payments in primary health care: a large-scale randomized controlled trial in Nigeria |
title_fullStr | Decentralized facility financing versus performance-based payments in primary health care: a large-scale randomized controlled trial in Nigeria |
title_full_unstemmed | Decentralized facility financing versus performance-based payments in primary health care: a large-scale randomized controlled trial in Nigeria |
title_short | Decentralized facility financing versus performance-based payments in primary health care: a large-scale randomized controlled trial in Nigeria |
title_sort | decentralized facility financing versus performance-based payments in primary health care: a large-scale randomized controlled trial in nigeria |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8452448/ https://www.ncbi.nlm.nih.gov/pubmed/34544415 http://dx.doi.org/10.1186/s12916-021-02092-4 |
work_keys_str_mv | AT khannamadhulika decentralizedfacilityfinancingversusperformancebasedpaymentsinprimaryhealthcarealargescalerandomizedcontrolledtrialinnigeria AT loevinsohnbenjamin decentralizedfacilityfinancingversusperformancebasedpaymentsinprimaryhealthcarealargescalerandomizedcontrolledtrialinnigeria AT pradhanelina decentralizedfacilityfinancingversusperformancebasedpaymentsinprimaryhealthcarealargescalerandomizedcontrolledtrialinnigeria AT fadeyibiopeyemi decentralizedfacilityfinancingversusperformancebasedpaymentsinprimaryhealthcarealargescalerandomizedcontrolledtrialinnigeria AT mcgeekevin decentralizedfacilityfinancingversusperformancebasedpaymentsinprimaryhealthcarealargescalerandomizedcontrolledtrialinnigeria AT odutoluoluwole decentralizedfacilityfinancingversusperformancebasedpaymentsinprimaryhealthcarealargescalerandomizedcontrolledtrialinnigeria AT fritschegyorgybela decentralizedfacilityfinancingversusperformancebasedpaymentsinprimaryhealthcarealargescalerandomizedcontrolledtrialinnigeria AT meriboleemmanuel decentralizedfacilityfinancingversusperformancebasedpaymentsinprimaryhealthcarealargescalerandomizedcontrolledtrialinnigeria AT vermeerschchristelmj decentralizedfacilityfinancingversusperformancebasedpaymentsinprimaryhealthcarealargescalerandomizedcontrolledtrialinnigeria AT kandpaleeshani decentralizedfacilityfinancingversusperformancebasedpaymentsinprimaryhealthcarealargescalerandomizedcontrolledtrialinnigeria |